Conning INC Decreased Johnson & Johnson (JNJ) Stake

April 16, 2018 - By Daniel Cummings

Johnson & Johnson (NYSE:JNJ) Corporate LogoDuring Q4 2017 the big money sentiment increased to 0.87. That’s change of 0.04, from 2017Q3’s 0.83. 35 investors sold all, 884 reduced holdings as JNJ ratio increased. 654 increased holdings while 143 funds took holdings. Funds hold 1.72 billion shares thus 0.40% more from 2017Q3’s 1.71 billion shares. Boys Arnold & Communications Incorporated holds 83,034 shs or 1.74% of its capital. Chatham Capital owns 57,562 shs. Alberta – Canada-based Mawer Investment Ltd has invested 1.62% in Johnson & Johnson (NYSE:JNJ). Moreover, Mraz Amerine & has 1.17% invested in Johnson & Johnson (NYSE:JNJ) for 27,417 shs. Fil Limited invested 1.88% of its capital in Johnson & Johnson (NYSE:JNJ). Community Fin Svcs Grp Incorporated Ltd Liability reported 1.15% stake. Greenwood Ltd Llc holds 1.8% of its capital in Johnson & Johnson (NYSE:JNJ) for 55,288 shs. Godsey Gibb Assocs owns 107,686 shs or 2.53% of their US capital. 3.96M were reported by Putnam Investments Limited Company. Nexus Invest Mgmt Incorporated accumulated 0.21% or 10,026 shs. Salem Invest Counselors has invested 2.63% in Johnson & Johnson (NYSE:JNJ). Btr Mgmt invested in 92,303 shs or 2.52% of the stock. Hudson Valley Inv Inc Adv owns 2.63% invested in Johnson & Johnson (NYSE:JNJ) for 76,300 shs. Meridian Investment Counsel owns 24,629 shs. Navellier And Associates owns 0.12% invested in Johnson & Johnson (NYSE:JNJ) for 4,455 shs.

JNJ registered $20.17 million net activity with 0 buys and 1 sale since February 15, 2018.

Conning Inc’s holdings in Johnson & Johnson (JNJ) is reduced by 6.92% based on its latest 2017Q4 regulatory filing with the SEC. By selling 24,817 shares Conning Inc made the stock sank with 9.21%. The institutional investor is holding 333,847 shares, compared to the 358,664 from the previous quarter. And the announced value of the major pharmaceuticals company is $46.65M for the 2017Q4. $350.41 billion is Johnson & Johnson’s market cap. The stock increased 0.15% or $0.19 during the last trading session, reaching $130.62.Johnson & Johnson has volume of 4.74M shares. Since April 16, 2017 JNJ has risen 1.12% and is uptrending. JNJ underperformed the S&P 500 by 10.43%.

About $80.03 billion and $3.03B US Long portfolio Conning Inc manages. It upped its stake in Westrock Co by 441,106 shares to 445,954 shares, valued at $28.19M in 2017Q4, according to the filing. Conning Inc has risen its stake in Exxon Mobil Corp (NYSE:XOM) and also increased its holding in Ishares Tr (CLY) by 264,017 shares in the quarter, for a total of 580,146 shares.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on April, 17. They expect $2.01 EPS, up 9.84 % or $0.18 from last year’s $1.83 per share. JNJ’s profit will be $5.39 billion for 16.25 P/E if the $2.01 EPS becomes a reality. After $1.74 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 15.52 % EPS growth.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

In total 13 analysts cover Johnson & Johnson (NYSE:JNJ). “Buy” rating has 7, “Sell” are 1, while 5 are “Hold”. 54% are bullish. 23 are the (NYSE:JNJ)’s analyst reports since October 17, 2017 according to StockzIntelligence Inc. On Wednesday, October 18 the firm has “Buy” rating given by Leerink Swann. On Tuesday, October 17 the stock has “Buy” rating by BMO Capital Markets. On Tuesday, January 23 the stock of Johnson & Johnson (NYSE:JNJ) has “Sell” rating given by BTIG Research. On Tuesday, January 2 the stock of Johnson & Johnson (NYSE:JNJ) earned “Neutral” rating by JP Morgan. On Tuesday, February 6 the company was maintained by Wells Fargo. On Wednesday, October 18 the rating was maintained by Wells Fargo with “Buy”. On Wednesday, October 18 the firm has “Buy” rating by Argus Research given. The stock rating was maintained by Wells Fargo with “Buy” on Friday, January 12. On Thursday, October 19 the stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given by Credit Suisse. On Monday, October 23 the rating was maintained by Citigroup with “Buy”.

Johnson & Johnson (NYSE:JNJ) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.